Isolation and Quarantine for Coronavirus Disease 2019 in the United States, 2020–2022
Clinical Infectious Diseases · 2023
DOI: 10.1093/cid/ciad163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von John E Oeltmann und 17 weiteren Autor:innen. Beteiligte Einrichtung: US Centers for Disease Control and Prevention, COVID-19 Response Team, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Patient Isolation, Quarantine, COVID-19. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, US Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Background
Public health programs varied in ability to reach people with coronavirus disease 2019 (COVID-19) and their contacts to encourage separation from others. For both adult case patients with COVID-19 and their contacts, we estimated the impact of contact tracing activities on separation behaviors from January 2020 until March 2022.
Methods
We used a probability-based panel survey of a nationally representative sample to gather data for estimates and comparisons.
Results
An estimated 64 255 351 adults reported a positive severe acute respiratory syndrome coronavirus 2 test result; 79.6% isolated for ≥5 days, 60.2% isolated for ≥10 days, and 79.2% self-notified contacts. A total of, 24 057 139 (37.7%) completed a case investigation, and 46.2% of them reported contacts to health officials. More adults who completed a case investigation isolated than those who did not complete a case investigation (≥5 days, 82.6% vs 78.2%, respectively; ≥10 days, 69.8% vs 54.8%; both P < .05). A total of 84 946 636 adults were contacts of a COVID-19 case patient. Of these, 73.1% learned of their exposure directly from a case patient; 49.4% quarantined for ≥5 days, 18.7% quarantined for ≥14 days, and 13.5% completed a contact tracing call. More quarantined among those who completed a contact tracing call than among those who did not complete a tracing call (≥5 days, 61.2% vs 48.5%, respectively; ≥14 days, 25.2% vs 18.0%; both P < .05).
Conclusions
Engagement in contact tracing was positively correlated with isolation and quarantine. However, most adults with COVID-19 isolated and self-notified contacts regardless of whether the public health workforce was able to reach them. Identifying and reaching contacts was challenging and limited the ability to promote quarantining, and testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- US Centers for Disease Control and Prevention, COVID-19 Response Team, Atlanta, Georgia, USA.
- Health Division, Mathematica, Princeton, New Jersey, USA.
- School of Public Health, Yale University, New Haven, Connecticut, USA.
Förderung
- Intramural CDC HHS
- US Centers for Disease Control and Prevention
Zitieren
APA
Oeltmann, J. E., Vohra, D., Matulewicz, H. H., DeLuca, N., Smith, J. P., Couzens, C., Lash, R. R., Harvey, B., Boyette, M., Edwards, A., Talboy, P. M., Dubose, O., Regan, P., Loosier, P., Caruso, E., Katz, D. J., Taylor, M. M., & Moonan, P. K. (2023). Isolation and Quarantine for Coronavirus Disease 2019 in the United States, 2020–2022. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad163
Vancouver
Oeltmann JE, Vohra D, Matulewicz HH, DeLuca N, Smith JP, Couzens C, et al. Isolation and Quarantine for Coronavirus Disease 2019 in the United States, 2020–2022. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciad163
BibTeX
@article{Oeltmann2023,
author = {Oeltmann, John E and Vohra, Divya and Matulewicz, Holly H and DeLuca, Nickolas and Smith, Jonathan P and Couzens, Chandra and Lash, R Ryan and Harvey, Barrington and Boyette, Melissa and Edwards, Alicia and Talboy, Philip M and Dubose, Odessa and Regan, Paul and Loosier, Penny and Caruso, Elise and Katz, Dolores J and Taylor, Melanie M and Moonan, Patrick K},
title = {Isolation and Quarantine for Coronavirus Disease 2019 in the United States, 2020–2022},
journal = {Clinical Infectious Diseases},
year = {2023},
doi = {10.1093/cid/ciad163}
}
EUVIMED